Clinical Trial Update: Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and tolerability of PQ912 in people with early Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PQ912

Snippet

Sponsor: Vivoryon Therapeutics N.V. | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED